Primary Mode of Therapy in Acute Decompensated Heart Failure:Comparison Between Usual Care Plus Tolvaptan and Ultrafiltration.
Phase of Trial: Phase IV
Latest Information Update: 12 Feb 2016
Price : $35 *
At a glance
- Drugs Tolvaptan (Primary) ; Furosemide
- Indications Decompensated heart failure
- Focus Biomarker; Pharmacodynamics
- Acronyms TUF
- 31 Aug 2018 Biomarkers information updated
- 27 Jan 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Feb 2015 Planned primary completion date changed from 1 May 2014 to 1 May 2015 as reported by ClinicalTrials.gov.